Apoptosis and chemotherapy resistanceLeukemia. 1999, Vol 13, Num 11, pp 1853-1892, issn 0887-6924Conference Proceedings

TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cellsGAZITT, Y.Leukemia. 1999, Vol 13, Num 11, pp 1817-1824, issn 0887-6924Conference Paper

Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalitiesMATHEW, S; BEHM, F. G; DALTON, J et al.Leukemia. 1999, Vol 13, Num 11, pp 1713-1720, issn 0887-6924Conference Paper

Molecular effects of topoisomerase II inhibitors in AML cell lines : correlation of apoptosis with topoisomerase II activity but not with DNA damage : Apoptosis and Chemotherapy ResistanceGIESELER, F; BAUER, E; NUESSLER, V et al.Leukemia. 1999, Vol 13, Num 11, pp 1859-1863, issn 0887-6924Conference Paper

Clinical relevance of minimal residual disease monitoring in non-Hodgkin's lymphomas : a critical reappraisal of molecular strategiesCORRADINI, P; LADETTO, M; PILERI, A et al.Leukemia. 1999, Vol 13, Num 11, pp 1691-1695, issn 0887-6924Conference Paper

Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines : Apoptosis and Chemotherapy ResistanceNUESSLER, V; STÖTZER, O; GULLIS, E et al.Leukemia. 1999, Vol 13, Num 11, pp 1864-1872, issn 0887-6924Conference Paper

Chronic myeloid leukemia from basics to bedsideTHIJSEN, S. F. T; SCHUURHUIS, G. J; VAN OOSTVEEN, J. W et al.Leukemia. 1999, Vol 13, Num 11, pp 1646-1674, issn 0887-6924Conference Paper

Expression of p16^INK4A and p14^ARF in hematological malignanciesTANIGUCHI, T; CHIKATSU, N; TAKAHASHI, S et al.Leukemia. 1999, Vol 13, Num 11, pp 1760-1769, issn 0887-6924Conference Paper

Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD)OLSSON, K; GERARD, C. J; ZEHNDER, J et al.Leukemia. 1999, Vol 13, Num 11, pp 1833-1842, issn 0887-6924Conference Paper

Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) : a clinicopathological studyTHIELE, J; KVASNICKA, H. M; BOELTKEN, B et al.Leukemia. 1999, Vol 13, Num 11, pp 1741-1748, issn 0887-6924Conference Paper

Drug-induced apoptosis in chronic lymphocytic leukemia : Apoptosis and Chemotherapy ResistanceSTOETZER, O. J; POGREBNIAK, A; SCHOLZ, M et al.Leukemia. 1999, Vol 13, Num 11, pp 1873-1880, issn 0887-6924Conference Paper

Detection of MUM1/IRF4-IgH fusion in multiple myelomaYOSHIDA, S; NAKAZAWA, N; IIDA, S et al.Leukemia. 1999, Vol 13, Num 11, pp 1812-1816, issn 0887-6924Conference Paper

Protection of committed murine haemopoietic progenitors against BCNU toxicity does not predict protection of primitive, multipotent spleen colony-forming cells : implications for chemoprotective gene therapyCHINNASAMY, N; RAFFERTY, J. A; LASHFORD, L. S et al.Leukemia. 1999, Vol 13, Num 11, pp 1776-1783, issn 0887-6924Conference Paper

Quantitation of leukemia clone-specific antigen gene rearrangements by a single-step PCR and fluorescence-based detection methodMAYER, S. P; GIAMELLI, J; SANDOVAL, C et al.Leukemia. 1999, Vol 13, Num 11, pp 1843-1852, issn 0887-6924Conference Paper

TEL-AML1 fusion identifies a subset of children with standard risk acute lymphoblastic leukemia who have an excellent prognosis when treated with therapy that includes a single delayed intensificationMALONEY, K. W; MCGAVRAN, L; MURPHY, J. R et al.Leukemia. 1999, Vol 13, Num 11, pp 1708-1712, issn 0887-6924Conference Paper

Accurate and rapid analysis of residual disease in patients with CML using specific fluorescent hybridization probes for real time quantitative RT-PCREMIG, M; SAUSSELE, S; WITTOR, H et al.Leukemia. 1999, Vol 13, Num 11, pp 1825-1832, issn 0887-6924Conference Paper

Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subtractions of patients with acute and chronic myeloid leukemiasBRENDEL, C; MOHR, B; SCHIMMELPFENNIG, C et al.Leukemia. 1999, Vol 13, Num 11, pp 1770-1775, issn 0887-6924Conference Paper

The Tel-PDGFRβ fusion gene produces a chronic myeloproliferative syndrome in transgenic miceRITCHIC, K. A; APRIKYAN, A. A. G; BOWEN-POPE, D. F et al.Leukemia. 1999, Vol 13, Num 11, pp 1790-1803, issn 0887-6924Conference Paper

Molecular analysis of chromosomal breakpoints in three examples of chromosomal translocation involving the TEL geneROMANA, S. P; POIREL, H; DELLA VALLE, V et al.Leukemia. 1999, Vol 13, Num 11, pp 1754-1759, issn 0887-6924Conference Paper

New system for assessing the prognosis of refractory anemia patientsMATSUDA, A; JINNAI, I; MATSUO, T et al.Leukemia. 1999, Vol 13, Num 11, pp 1727-1734, issn 0887-6924Conference Paper

Secondary acute myeloid leukemia with inv(16) : report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapySEYMOUR, J. F; JUNEJA, S. K; CAMPBELL, L. J et al.Leukemia. 1999, Vol 13, Num 11, pp 1735-1740, issn 0887-6924Conference Paper

Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) studyPULLEN, J; SHUSTER, J. J; LINK, M et al.Leukemia. 1999, Vol 13, Num 11, pp 1696-1707, issn 0887-6924Conference Paper

Expression of Bcl-2-related genes in normal and AML progenitors : changes induced by chemotherapy and retinoic acid : Apoptosis and Chemotherapy ResistanceANDREEFF, M; JIANG, S; ESTEY, E. H et al.Leukemia. 1999, Vol 13, Num 11, pp 1881-1892, issn 0887-6924Conference Paper